Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.5949
-0.0517 (-8.00%)
At close: Jul 13, 2026, 4:00 PM EDT
0.5612
-0.0337 (-5.66%)
After-hours: Jul 13, 2026, 7:53 PM EDT
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$52,571
Profits / Employee
-$1,361,417
Market Cap
14.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 7 | 0 | - |
| Aug 31, 2024 | 7 | 2 | 40.00% |
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| IN8bio | 18 |
| Cocrystal Pharma | 10 |
| Intensity Therapeutics | 7 |
| Tempest Therapeutics | 5 |
| Pasithea Therapeutics | 5 |
| GT Biopharma | 1 |
LEXX News
- 16 hours ago - Lexaria Bioscience Quarterly report: Q3 2026 - Filings
- 7 days ago - Lexaria Updates Business Development - TheNewswire
- 18 days ago - Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing - TheFly
- 18 days ago - Lexaria's Human Study GLP-1-H26-7 has Begun Dosing on Schedule - TheNewswire
- 18 days ago - Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule - Accesswire
- 20 days ago - Lexaria Bioscience begins dosing in animal study GLP-1-A26-1 - TheFly
- 20 days ago - Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule - Accesswire
- 20 days ago - Lexaria's Animal Study GLP-1-A26-1 has Begun Dosing on Schedule - TheNewswire